| Literature DB >> 32985483 |
Jun-Jie Sun1, Xue-Qun Pan2, Ru Yang3, Zhi-Shuai Jin4, Yi-Hui Li5, Jun Liu3, Da-Xing Wu4.
Abstract
Perceiving pitch is a central function of the human auditory system; congenital amusia is a disorder of pitch perception. The underlying neural mechanisms of congenital amusia have been actively discussed. However, little attention has been paid to the changes in the motor rain within congenital amusia. In this case-control study, 17 participants with congenital amusia and 14 healthy controls underwent functional magnetic resonance imaging while resting with their eyes closed. A voxel-based degree centrality method was used to identify abnormal functional network centrality by comparing degree centrality values between the congenital amusia group and the healthy control group. We found decreased degree centrality values in the right primary sensorimotor areas in participants with congenital amusia relative to controls, indicating potentially decreased centrality of the corresponding brain regions in the auditory-sensory motor feedback network. We found a significant positive correlation between the degree centrality values and the Montreal Battery of Evaluation of Amusia scores. In conclusion, our study identified novel, hitherto undiscussed candidate brain regions that may partly contribute to or be modulated by congenital amusia. Our evidence supports the view that sensorimotor coupling plays an important role in memory and musical discrimination. The study was approved by the Ethics Committee of the Second Xiangya Hospital, Central South University, China (No. WDX20180101GZ01) on February 9, 2019.Entities:
Keywords: congenital amusia; degree centrality; lifelong impairment; local functional connectivity; music discrimination; primary motor area; primary sensorimotor area; primary sensory area; resting-state functional magnetic resonance imaging; voxel-based analysis
Year: 2021 PMID: 32985483 PMCID: PMC7996008 DOI: 10.4103/1673-5374.293154
Source DB: PubMed Journal: Neural Regen Res ISSN: 1673-5374 Impact factor: 5.135
STROBE Statement—checklist of items that should be included in reports of observational studies
| Item No. | Recommendation | Page No. | |
|---|---|---|---|
| 1 | ( | 1 | |
| ( | 1 | ||
| Background/rationale | 2 | Explain the scientific background and rationale for the investigation being reported | 1 |
| Objectives | 3 | State specific objectives, including any prespecified hypotheses | 2 |
| Study design | 4 | Present key elements of study design early in the paper | 2 |
| Setting | 5 | Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection | 2 |
| Participants | 6 | 2 | |
| 2 | |||
| Variables | 7 | Clearly define group outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable | 2 |
| Data sources/ measurement | 8* | For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group | 2 |
| Bias | 9 | Describe any efforts to address potential sources of bias | 2 |
| Study size | 10 | Explain how the study size was arrived at | 2 |
| Quantitative variables | 11 | Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why | 2 |
| Statistical methods | 12 | ( | 3 |
| ( | 3 | ||
| ( | |||
| 2 | |||
| ( | 3 | ||
| Participants | 13* | (a) Report numbers of individuals at each stage of study—eg numbers potentigroupy eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed | 3 |
| (b) Give reasons for non-participation at each stage | 3 | ||
| (c) Consider use of a flow diagram | 2-3 | ||
| Descriptive data | 14* | (a) Give characteristics of study participants (eg demographic, clinical, social) and information on exposures and potential confounders | 3 |
| (b) Indicate number of participants with missing data for each variable of interest | 3 | ||
| (c) Cohort study—Summarise follow-up time (eg, average and total amount) | |||
| Outcome data | 15* | ||
| 3 | |||
| Main results | 16 | ( | 3 |
| ( | 3 | ||
| ( | None | ||
| Other analyses | 17 | Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analyses | 3-4 |
| Key results | 18 | Summarise key results with reference to study objectives | 4 |
| Limitations | 19 | Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any | 5 |
| potential bias | |||
| Interpretation | 20 | Give a cautious overgroup interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and | 4-5 |
| other relevant evidence | |||
| Generalisability | 21 | Discuss the generalisability (external validity) of the study results | 4-5 |
| Funding | 22 | Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based | 6 |
*Give information separately for cases and controls in case-control studies and, if applicable, for exposed and unexposed groups in cohort and cross-sectional studies.
Characteristics of the CA and healthy controls groups
| Congenital amusics | Healthy controls | ||
|---|---|---|---|
| Number (male/female) | 17 (12/5) | 14 (7/7) | 0.288* |
| Age (yr) | 18.294±0.588 | 18.642±0.633 | 0.123† |
| Framewise displacement | 0.056±0.221 | 0.583±0.295 | 0.791† |
| Education (yr) | 13.176±0.393 | 13.214±0.426 | 0.799† |
| Melodic discrimination | |||
| Violate key | 18.824±2.921 | 27.571±1.697 | 0.000† |
| Pitch contour | 20.353±3.141 | 28.429±1.399 | 0.000† |
| Pitch interval | 19.529±3.044 | 27.857±1.657 | 0.000† |
| Mean scores | 19.510±2.169 | 27.953±0.941 | 0.000† |
| Rhythmic discrimination | 19.647±2.178 | 27.357±1.151 | 0.000† |
| Metre | 19.765±4.409 | 25.296±3.338 | 0.001† |
| Memory | 20.882±3.638 | 28.643±1.447 | 0.000† |
| MBEA mean scores | 19.833±1.631 | 27.524±0.969 | 0.000† |
Data are expressed as the mean ± SD, except for number data. All variables conformed to homogeneity of variance. Fisher's exact test (*) and two-sample t-tests (†) were used to test between-group differences in categorical and continuous variables, respectively. MBEA: Montreal Battery of Evaluation of Amusia; violate key, pitch contour, pitch interval, rhythm, meter, and memory: subscales of the MBEA.
Abnormal functional hubs located by cluster peak information in the CA group assessed by degree centrality indices
| Brain region | Peak | Cluster size (voxels) | Peak MNI coordinates | ||
|---|---|---|---|---|---|
| Precentral_R | –4.196 | 15 | 51 | 3 | 24 |
| Postcentral_R | –5.36 | 54 | 54 | –6 | 27 |
The significance level was set at P < 0.05 (corrected for permutations with threshold-free cluster-enhancement). CA: Congenital amusia; MNI: Montreal Neurological Institute; R: right.